Drugs

From Discovery to Approval

NG, Rick Taal: Engels

Gebonden

€ 116,40

Afwijkende levertijd: 18-20 werkdagen
Drugs

Gebonden

€ 116,40

Nieuwe boeken gratis bezorgd t/m 31-12-2021 naar NL*
Altijd de laagste prijs voor nieuwe Nederlandstalige boeken
Verlengde retourtermijn: ruilen of retourneren t/m 10 januari 2022
Koop lokaal, ook online!
Bekijk winkelvoorraad

THIRD EDITION

DRUGS
From Discovery to Approval

The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products.

Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts and then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The third edition incorporates the latest developments and updates in the pharmaceutical community, provides more comprehensive coverage of topics, and includes more materials and case studies suited to college and university use. Biotechnology is a dynamic field with changes across R&D, clinical trials, manufacturing, and regulatory processes; the third edition of the text provides timely updates for those in this rapidly growing field. <>

  • Revised edition will have greater appeal to students with the inclusion of more materials and case studies suited to college and university use
  • Includes the latest developments and updates
  • Increased appeal by provision of more comprehensive topics
  • ISBN
    9781118907276
    Vorm
    Gebonden
    Uitgever
    John Wiley & Sons Inc
    Druk
    1e
    Verschenen
    01-01-2015
    Taal
    Engels
    Pagina's
    560 pp.
    Genre
    Literaire fictie
    Geen recensies beschikbaar.
    pro-mbooks3 : libris